secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2023-11-01T23:59:59+00:00
Accession:  0001193125-23-268167
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma reaches deal with activist investors; declares $1.75/share dividend, adds three new directors
--------------------------------------------------------------------------------

- Immediate dividend of $1.75 per share paid to all stockholders; potential additional $9.33M return contingent on ME-344 trial results or Board decision.
- Three new directors appointed: James Flynn, Taheer Datoo (Anson/Cable Car designees) and Steven Wood (mutual). Three former directors resigned.
- Board forms Capital Allocation Committee to advise on strategic capital allocation for drug programs and value creation.
- Investors agree to standstill, withdraw consent solicitation, and vote for Company slate at 2024 and 2025 annual meetings.
- Agreement aims to avoid proxy contest; Company expects near-term data readouts for voruciclib and ME-344 in first half 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523268167/0001193125-23-268167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523268167/d514927d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-268167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer